Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Agent ZD-1839 (NSC-715055, IND-61187) in Patients With Advanced Head and Neck Carcinoma or Non-Small Cell Lung Cancer Aged 75 Years and Older (and in a Cohort of Patients 50 Years Old and Younger)

NCT00068497 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00068497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00068497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Agent ZD-1839 (NSC-715055, IND-61187) in Patients With Advanced Head and Neck Carcinoma or Non-Small Cell Lung Cancer Aged 75 Years and Older (and in a Cohort of Patients 50 Years Old and Younger)
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2003
Completion date
Not reported
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic thyroid cancer, insular thyroid cancer, metastatic parathyroid cancer, recurrent adenoid cystic carcinoma of the oral cavity, recurrent basal cell carcinoma of the lip, recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity, recurrent inverted papilloma of the paranasal sinus and nasal cavity, recurrent lymphoepithelioma of the nasopharynx, recurrent lymphoepithelioma of the oropharynx, recurrent metastatic squamous neck cancer with occult primary, recurrent midline lethal granuloma of the paranasal sinus and nasal cavity, recurrent mucoepidermoid carcinoma of the oral cavity, recurrent non-small cell lung cancer, recurrent parathyroid cancer, recurrent salivary gland cancer, recurrent squamous cell carcinoma of the hypopharynx, recurrent squamous cell carcinoma of the larynx, recurrent squamous cell carcinoma of the lip and oral cavity, recurrent squamous cell carcinoma of the nasopharynx, recurrent squamous cell carcinoma of the oropharynx, recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity, recurrent thyroid cancer, recurrent verrucous carcinoma of the larynx, stage iii follicular thyroid cancer, stage iii papillary thyroid cancer, stage iii salivary gland cancer, stage iii squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the larynx, stage iii verrucous carcinoma of the larynx, stage iiib non-small cell lung cancer, stage iv lymphoepithelioma of the nasopharynx, stage iv non-small cell lung cancer, stage iv squamous cell carcinoma of the hypopharynx, stage iv squamous cell carcinoma of the nasopharynx, stage iva adenoid cystic carcinoma of the oral cavity, stage iva basal cell carcinoma of the lip, stage iva esthesioneuroblastoma of the paranasal sinus and nasal cavity, stage iva follicular thyroid cancer, stage iva inverted papilloma of the paranasal sinus and nasal cavity, stage iva lymphoepithelioma of the oropharynx, stage iva midline lethal granuloma of the paranasal sinus and nasal cavity, stage iva mucoepidermoid carcinoma of the oral cavity, stage iva papillary thyroid cancer, stage iva salivary gland cancer, stage iva squamous cell carcinoma of the larynx, stage iva squamous cell carcinoma of the lip and oral cavity, stage iva squamous cell carcinoma of the oropharynx, stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity, stage iva verrucous carcinoma of the larynx, stage iva verrucous carcinoma of the oral cavity, stage ivb adenoid cystic carcinoma of the oral cavity, stage ivb basal cell carcinoma of the lip, stage ivb esthesioneuroblastoma of the paranasal sinus and nasal cavity, stage ivb follicular thyroid cancer, stage ivb inverted papilloma of the paranasal sinus and nasal cavity, stage ivb lymphoepithelioma of the oropharynx, stage ivb midline lethal granuloma of the paranasal sinus and nasal cavity, stage ivb mucoepidermoid carcinoma of the oral cavity, stage ivb papillary thyroid cancer, stage ivb salivary gland cancer, stage ivb squamous cell carcinoma of the larynx, stage ivb squamous cell carcinoma of the lip and oral cavity, stage ivb squamous cell carcinoma of the oropharynx, stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity, stage ivb verrucous carcinoma of the larynx, stage ivb verrucous carcinoma of the oral cavity, stage ivc adenoid cystic carcinoma of the oral cavity, stage ivc basal cell carcinoma of the lip, stage ivc esthesioneuroblastoma of the paranasal sinus and nasal cavity, stage ivc follicular thyroid cancer, stage ivc inverted papilloma of the paranasal sinus and nasal cavity, stage ivc lymphoepithelioma of the oropharynx, stage ivc midline lethal granuloma of the paranasal sinus and nasal cavity, stage ivc mucoepidermoid carcinoma of the oral cavity, stage ivc papillary thyroid cancer, stage ivc salivary gland cancer, stage ivc squamous cell carcinoma of the larynx, stage ivc squamous cell carcinoma of the lip and oral cavity, stage ivc squamous cell carcinoma of the oropharynx, stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity, stage ivc verrucous carcinoma of the larynx, stage ivc verrucous carcinoma of the oral cavity, thryoid gland nonmedullary carcinoma, thyroid gland medullary carcinoma, tongue cancer, untreated metastatic squamous neck cancer with occult primary